Meta-analysis of the therapeutic effect of hepatectomy versus radiofrequency ablation for the treatment of hepatocellular carcinoma

Surgical Laparoscopy, Endoscopy and Percutaneous Techniques

Volumn 20, Issue 3, 2010, Pages 130-140

  Liu, Zhihua ^a   Zhou, Yukun ^a   Zhang, Peng ^a   Qin, Huanlong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Hepatectomy; Hepatocellular carcinoma; Meta analysis; Radiofrequency ablation; Surgical resection

Indexed keywords

ANEMIA; ASCITES; CANCER RECURRENCE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CLINICAL TRIAL; COMPARATIVE STUDY; DEATH; DIAPHRAGM INJURY; DISEASE FREE SURVIVAL; HEART DISEASE; HEMOPERITONEUM; HUMAN; HYDROTHORAX; INTERMETHOD COMPARISON; JAUNDICE; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER RESECTION; LIVER VEIN THROMBOSIS; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; PLEURA EFFUSION; PNEUMONIA; PNEUMOTHORAX; PORTAL VEIN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; SENSITIVITY ANALYSIS; SURVIVAL RATE; SYSTEMATIC REVIEW; THERAPY EFFECT; ULCER;

CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; TREATMENT OUTCOME;

EID: 77953980144     PISSN: 15304515     EISSN: 15344908     Source Type: Journal    
DOI: 10.1097/SLE.0b013e3181d823df     Document Type: Review

References (52)

1. El-Serag HB. Hepatocellular carcinoma and hepatitis C in the United States. Hepatology. 2002;36(5 suppl 1):S74-S83.
2. El-Serag HB. Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol. 2002;35(5 suppl 2):S72-S78.
3. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol. 2001;35:421-430.
4. Livraghi T. Guidelines for treatment of liver cancer. Eur J Ultrasound. 2001;13:167-176.
5. Marin-Hargreaves G, Azoulay D, Bismuth H. Hepatocellular carcinoma: surgical indications and results. Crit Rev Oncol Hematol. 2003;47:13-27.
6. Lai EC, Fan ST, Lo CM, et al. Hepatic resection for hepatocellular carcinoma: an audit of 343 patients. Ann Surg. 1995; 221:291-298.
7. Ikai I, Itai Y, Okita K, et al. Report of the 15th follow-up survey of primary liver cancer. Hepatol Res. 2004;28:21-29.
8. Arii S, Yamaoka Y, Futagawa S, et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology. 2000;32: 1224-1229.
9. Fried MW. Treatment of hepatocellular carcinoma: medical options. Liver Transpl Surg. 1998;4(5 suppl 1):S92-S97.
10. Minagawa M, Makuuchi M, Takayama T, et al. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg. 2003;238:703-710.
11. Cherqui D, Laurent A, Mocellin N, et al. Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation. Ann Surg. 2009; 250:738-746.
12. Hashikura Y, Kawasaki S, Terada M, et al. Long-term results of living-related donor liver graft transplantation: a singlecenter analysis of 110 transplants. Transplantation. 2001;72: 95-99.
13. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907-1917.
14. Curley SA. Radiofrequency ablation of malignant liver tumors. Ann Surg Oncol. 2003;10:338-347.
15. Grazi GL, Ercolani G, Pierangeli F, et al. Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann Surg. 2001;234:71-78.
16. Poon RT, Fan ST, Lo CM, et al. Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified? Ann Surg. 2002;236:602-611.
17. Poon RT, Fan ST, Lo CM, et al. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg. 2001;234:63-70.
18. Curley SA. Radiofrequency ablation of malignant liver tumors. Oncologist. 2001;6:14-23.
19. Diaz-Sanchez A, Matilla A, Nunez O, et al. Influence of treatment of hepatocellular carcinoma before liver transplantation on postransplant tumor recurrence and survival. Gastroenterol Hepatol. 2010;33:155-164.
20. Lau WY, Leung TWT, Yu SCH, et al. Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future. Ann Surg. 2003;237:171-179.
21. Sanchez W. Expanding transplant criteria for hepatocellular carcinoma: small steps down a long road. Hepatology. 2009;49: 724-725.
22. Lencioni RA, Allgaier HP, Cioni D, et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radiofrequency thermal ablation versus percutaneous ethanol injection. Radiology. 2003;228:235-240.
23. Vivarelli M, Guglielmi AF, Ruzzenente A, et al. Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg. 2004;240:102-107.
24. Hong SN, Lee SY, Choi MS, et al. Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function. J Clin Gastroenterol. 2005;39:247-252.
25. Montorsi M, Santambrogio R, Bianchi P, et al. Survival and recurrences after hepatic resection or radiofreauency for hepatocellular carcinoma in cirrhotic patients: a multivariate analysis. J Gastrointest Surg. 2005;9:62-67.
26. Yamakado K, Nakatsuka A, Ohmori S, et al. Radiofrequency ablation combined with chemoembolization in hepatocellular carcinoma: treatment response based on tumor size and morphology. J Vasc Interv Radiol. 2002;13:1225-1232.
27. Yamakado K, Nakatsuka A, Akeboshi M, et al. Combination therapy with radiofrequency ablation and transcatheter chemoembolization for the treatment of hepatocellular carcinoma: short-term recurrences and survival. Oncol Rep. 2004; 11:105-109.
28. Tanaka K, Nakamura S, Numata K, et al. Hepatocellular carcinoma: treatment with percutaneous ethanol injection and transcatheter arterial embolization. Radiology. 1992;185: 457-460.
29. Yang Z, Zheng Q, Wang Z. Meta-analysis of the need for nasogastric or nasojejunal decompression after gastrectomy for gastric cancer. Br J Surg. 2008;95:809-816.
30. Guglielmi A, Ruzzenente A, Valdegamberi A, et al. Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis. J Gastrointest Surg. 2008;12:192-198.
31. Liang HH, Chen MS, Peng ZW, et al. Percutaneous radiofrequency ablation versus repeat hepatectomy for recurrent hepatocellular carcinoma: a retrospective study. Ann Surgl Oncol. 2008;15:3484-3493.
32. Wong J, Lee KF, Lee PSF, et al. Radiofrequency ablation for 110 malignant liver tumours: preliminary results on percutaneous and surgical approaches. Asian J Surg. 2009;32:13-20.
33. Yamakado K, Nakatsuka A, Takaki H, et al. Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy. Radiology. 2008; 247:260-266.
34. Ogihara M, Wong LL, Machi J. Radiofrequency ablation versus surgical resection for single nodule hepatocellular carcinoma: long-term outcomes. HPB (Oxford). 2005;7:214-221.
35. Abu-Hilal M, Primrose JN, Casaril A, et al. Surgical resection versus radiofrequency ablation in the treatment of small unifocal hepatocellular carcinoma. J Gastrointest Surg. 2008;12: 1521-1526.
36. Ueno S, Sakoda M, Kubo F, et al. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria. J Hepatobiliary Pancreat Surg. 2009; 16:359-366.
37. Poon RT, Fan ST, Tsang FH, et al. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective. Ann Surg. 2002;235:466-486.
38. Guglielmi A, Ruzzenente A, Battocchia A, et al. Radiofrequency ablation of hepatocellular carcinoma in cirrhotic patients. Hepatogastroenterology. 2003;50:480-484.
39. Machi J, Uchida S, Sumida K, et al. Ultrasound-guided radiofrequency thermal ablation of liver tumors: percutaneous, laparoscopic, and open surgical approaches. J Gastrointest Surg. 2001;5:477-489.
40. Mazzaferro V, Battiston C, Perrone S, et al. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg. 2004;240:900-909.
41. Racz GB, Ruiz-Lopez R. Radiofrequency procedures. Pain Pract. 2006;6:46-50.
42. Lau WY. The history of liver surgery. J R Coll Surg Edinb. 1997;42:303-309.
43. Lau WY, Lai EC. Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreat Dis Int. 2008;7:237-257.
44. Okuwaki Y, Nakazawa T, Kokubu S, et al. Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma. Am J Gastroenterol. 2009;104:2747-2753.
45. Mulier S, Ni YC, Jamart J, et al. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg. 2005;242:158-171.
46. Suenaga M, Sugiura H, Kokuba Y, et al. Repeated hepatic resection for recurrent hepatocellular carcinoma in eighteen cases. Surgery. 1994;115:452-457.
47. Balk EM, Bonis PA, Moskowitz H, et al. Correlation of quality measures with estimates of treatment effect in metaanalyses of randomized controlled trials. JAMA. 2002;287: 2973-2982.
48. El-Serag HB, Mallat DB, Rabeneck L. Management of the single liver nodule in a cirrhotic patient: a decision analysis model. J Clin Gastroenterol. 2005;39:152-159.
49. Taura K, Ikai I, Hatano E, et al. Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged survival of patients with hepatocellular carcinoma undergoing hepatic resection: an analysis of 610 patients over 16 years old. Ann Surg. 2006;244:265-273.
50. Johnson PJ. Hepatocellular carcinoma: is current therapy really altering outcome? Gut. 2002;51:459-462.
51. Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology. 2002;35:519-524.
52. Ogata S, Belghiti J, Varma D, et al. Two hundred liver hanging maneuvers for major hepatectomy: a single-center experience. Ann Surg. 2007;245:31-35.